Aziende Chimiche Riunite Angelini Francesco S.p.a
Clinical trials sponsored by Aziende Chimiche Riunite Angelini Francesco S.p.a, explained in plain language.
-
New epilepsy drug shows promise in real-world italian study
Disease control OngoingThis study looks at how cenobamate works in adults whose focal seizures are not controlled by at least two other epilepsy drugs. Researchers will track seizure frequency before and during treatment to see if seizures drop by half or more. The goal is to better understand the drug…
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
Real-World epilepsy study tracks Add-On drug effectiveness
Knowledge-focused OngoingThis study observes 300 adults with focal onset seizures who are starting an add-on anti-seizure medication. Researchers will track changes in seizure frequency and quality of life over 12 months in real-world settings. The goal is to understand how well these medications work ou…
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Knowledge-focused
Last updated May 26, 2026 08:58 UTC